MGC Pharmaceuticals (LON: MXC) announced Tuesday that the construction of the CimetrA production facility in Malta has been completed on schedule.
MGC received a €3.1million cash grant from the Maltese Government via Malta Enterprise to fund the majority of the facility’s construction and equipment fitout.
The fully compliant EU GMP production facility will have the capacity to produce over 20,000 units in liquid dose form per day, which is double the number initially planned. MGC said that makes it an important part of MGC’s manufacturing pipeline and meets CimetrA’s near-term demand.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The facility also creates a European manufacturing hub for CimetrA and the company’s other liquid form dose medicines.
Roby Zomer, Co-founder and Managing Director of MGC Pharma, said: “The completion of the construction of the CimetrA facility in Malta, the company’s second EU based production facility, continues to strengthen our strategic position in pharmaceuticals development and manufacturing, and provides the company with flexible production capacity, which includes production of CimetrA, MGC Pharma’s proprietary treatment for the symptoms of COVID-19.”
MGC Pharma shares are up 0.59% at 2.565p at the time of writing. on Monday, MGC Pharma announced that a dosing study for CimetrA had been approved.
Should You Invest in MGC Pharmaceuticals Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
